BNY Mellon Research Growth Fund Q4 2024 Commentary
BNY Mellon Research Growth Fund (Class A at NAV) underperformed its benchmark during Q4 2024. Click here to read the full ...
Analysis-Investors, advisors flock to 'buffer' ETFs as markets sell off
By Suzanne McGee (Reuters) -Investors are increasingly taking refuge from the tumultuous U.S. stock market by pouring into a ...
Lam Research: Riding The AI Tailwind For Long-Term Gains
Lam Research remains a strong long-term investment in the semiconductor space, driven by AI infrastructure growth and a broad ...
Consumer Sentiment Tumbles Further in March With Even Republicans Losing Faith
While Michigan’s survey often shows sharp partisan differences in sentiment, the March survey found a 10% decline in future ...
Pensions & Investments31m
Denmark's AkademikerPension drops Tesla over workers' rights, Musk's political meddling
Denmark’s AkademikerPension is dropping Tesla from its investment universe over employee rights issues and because CEO Elon ...
Idaho Business Review34m
Why supporting Idaho’s nonprofit sector is a smart investment
Idaho’s nonprofits drive economic stability & community well-being. Learn how businesses can invest in nonprofits for a ...
McKnight's Senior Living13m
Solera, Goodwin Living grow through acquisitions, affiliation
Solera Senior Living has expanded its footprint with the acquisition of five SageLife senior living communities in the Mid-Atlantic region.
Why Summit Therapeutics Stock Was Winning This Week
A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock price pop. The person behind the news was Evercore ISI pundit Cory Kasimov ...
Almost half of Americans ‘aren’t ready to retire’, study reveals — here’s why making a plan for income in retirement is crucial for your golden years
Without a well-defined plan for spending in retirement, Americans could be facing unexpected and unnecessary stress. Allianz ...